Skip to content

Efficacy Evaluation of Blood Peach Extract and Rose Apple Extract on Skin

Efficacy Evaluation of Blood Peach Extract and Rose Apple Extract on Skin

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06854419
Enrollment
75
Registered
2025-03-03
Start date
2025-04-07
Completion date
2025-07-15
Last updated
2025-07-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dermatology

Keywords

skin analysis, skin care products

Brief summary

Evaluate the effects of blood peach extract drink and rose apple extract drink on enhancing hemoglobin and iron levels, and improving skin health.

Interventions

DIETARY_SUPPLEMENTPlacebo Drink

Take one bottle of the product every morning on an empty stomach

DIETARY_SUPPLEMENTBlood Peach Extract Drink

Take one bottle of the product every morning on an empty stomach

DIETARY_SUPPLEMENTRose Apple Extract Drink

Take one bottle of the product every morning on an empty stomach

Sponsors

TCI Co., Ltd.
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER
Masking
DOUBLE (Subject, Investigator)

Eligibility

Sex/Gender
FEMALE
Age
20 Years to 65 Years
Healthy volunteers
Yes

Inclusion criteria

* Healthy adult females aged 20 to 65; * Preferably those with pale complexion or signs of iron deficiency anemia.

Exclusion criteria

* Currently undergoing or having undergone any medical beauty treatments within the past month (including skincare, laser treatments, chemical peel, injections, or cosmetic surgery); * Outdoor workers (exposed to sunlight for more than 5 hours daily); * Pregnant, breastfeeding, or planning to become pregnant during the trial (self-reported); * Individuals with heart, liver, kidney, endocrine, or other significant organic diseases (self-reported); * Individuals who have undergone major surgery (according to medical history); * Long-term medication users; * Individuals with mental health disorders; * Those who are already regularly taking iron supplements; * Faculty or staff members who are currently enrolled in the principal investigator's courses.

Design outcomes

Primary

MeasureTime frameDescription
the volume of skin wrinklesVolume change from Baseline skin wrinkles at 8 weeksIRV full-face skin analyzer was utilized to measure skin wrinkles. Units: arbitrary units
the roughness of skin textureRating skin roughness from Baseline skin texture at 8 weeksIRV full-face skin analyzer was utilized to measure skin texture. Units: arbitrary units

Secondary

MeasureTime frameDescription
the change of skin rednessChange from Baseline skin redness at 8 weeksColorimeter was utilized to measure skin redness. Units: arbitrary units
the change of mean corpuscular hemoglobin concentration (M.C.H.C) level of bloodChange from Baseline M.C.H.C level at 8 weeksvenous blood was sampled to measure M.C.H.C level
the change of ferrous level of bloodChange from Baseline ferrous level at 8 weeksvenous blood was sampled to measure ferrous level
the change of ferritin level of bloodChange from Baseline ferritin level at 8 weeksvenous blood was sampled to measure ferritin level
the change of Total Iron Binding Capacity (TIBC) level of bloodChange from Baseline TIBC level at 8 weeksvenous blood was sampled to measure TIBC level
the change of unsaturated iron-binding capacity (UIBC) level of bloodChange from Baseline UIBC level at 8 weeksvenous blood was sampled to measure UIBC level
the change of skin elasticityChange from Baseline skin elasticity at 8 weeksCutometer® was utilized to measure skin elasticity. Units: arbitrary units
the change of skin collagen densityChange from Baseline skin collagen density at 8 weeksDermalab® Combo was utilized to measure skin collagen density. Units: arbitrary units
the change of skin poresChange from Baseline skin pores at 8 weeksIRV full-face skin analyzer was utilized to measure skin pores. Units: arbitrary units
the change of skin toneChange from Baseline skin tone at 8 weeksIRV full-face skin analyzer was utilized to measure skin tone. Units: arbitrary units
the change of skin hydrationChange from Baseline skin hydration at 8 weeksCorneometer® was utilized to measure skin hydration. Units: arbitrary units
the change of skin melanin/erythema indexChange from Baseline skin melanin/erythema index at 8 weeksMexameter® was utilized to measure skin melanin/erythema index. Units: arbitrary units
the change of lip rednessChange from Baseline lip redness at 8 weeksAntera 3D® was utilized to measure lip redness. Units: arbitrary units
the change of Red Blood Cells (RBC) Count of bloodChange from Baseline RBC count at 8 weeksvenous blood was sampled to measure RBC count
the change of hemoglobin level of bloodChange from Baseline hemoglobin level at 8 weeksvenous blood was sampled to measure hemoglobin level
the change of mean corpuscular volume (M.C.V) level of bloodChange from Baseline M.C.V level at 8 weeksvenous blood was sampled to measure M.C.V level

Other

MeasureTime frameDescription
the change of Advanced glycation end products (AGEs) level of bloodchange from Baseline AGEs level at 8 weeksvenous blood was sampled to measure AGEs level
The change of self-assessment skin and metabolic circulation conditionChange from Baseline skin and metabolic circulation condition at 8 weeksA self-assessment questionnaire was collected to evaluate skin and metabolic circulation condition. As for the evalutation of skin condition, the higher score the better; As for evaluation of metabolic circulation condition, the higher score the worse.
the change of liver function biomarkers (AST, ALT) of bloodchange from Baseline liver function biomarkers at 8 weeksvenous blood was sampled to measure liver function biomarkers
the change of renal function biomarkers (creatinine, BUN) of bloodchange from Baseline renal function biomarkers at 8 weeksvenous blood was sampled to measure renal function biomarkers
the change of fasting glucose level of bloodchange from Baseline fasting glucose level at 8 weeksvenous blood was sampled to measure fasting glucose level

Countries

Taiwan

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026